Candel Therapeutics, Inc. (CADL) Earnings
|
Expand Research on CADL
| Next EPS Date | 8/19/26 | EPS Growth Rate | -166.7% |
|---|---|---|---|
| Average EPS % Beat Rate | -7.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/26  |
Q226 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/14/26 |
Q126 | -$0.14 | -$0.34 | +$0.20 | N/A | N/A | N/A |  | | Details | |
| 5/7/26 |
Q126 | N/A | -$0.34 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/12/26 |
Q425 | -$0.54 | -$0.25 | -$0.29 | N/A | N/A | N/A | | | Details | |
| 11/13/25 | Q325 | -$0.21 | -$0.18 | -$0.03 | N/A | N/A | N/A | | | Details | |
| 11/11/25 |
Q325 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/10/25 |
Q325 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/25 |
Q325 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A |
